Jacoline E C Bromberg
Overview
Explore the profile of Jacoline E C Bromberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
4431
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23
Hau P, Frappaz D, Hovey E, McCabe M, Pajtler K, Wiestler B, et al.
Cancers (Basel)
. 2021 Jul;
13(14).
PMID: 34298664
Medulloblastoma is a rare brain malignancy. Patients after puberty are rare and bear an intermediate prognosis. Standard treatment consists of maximal resection plus radio-chemotherapy. Treatment toxicity is high and produces...
12.
Van Dijck R, Doorduijn J, Bromberg J
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33923396
Primary central nervous system lymphoma (PCNSL) is a type of non-Hodgkin lymphoma limited to the central nervous system. It has a poor prognosis. Consensus has been reached on the treatment...
13.
Extent of radiological response does not reflect survival in primary central nervous system lymphoma
van der Meulen M, Postma A, Smits M, Bakunina K, Minnema M, Seute T, et al.
Neurooncol Adv
. 2021 Feb;
3(1):vdab007.
PMID: 33615224
Background: In primary central nervous system lymphoma (PCNSL), small enhancing lesions can persist after treatment. It is unknown whether a difference in response category (complete response [CR], complete response unconfirmed...
14.
van der Meulen M, Dirven L, Bakunina K, van den Bent M, Issa S, Doorduijn J, et al.
J Neurooncol
. 2021 Feb;
152(2):357-362.
PMID: 33611761
Introduction: To assess the value of the Mini-Mental State Examination (MMSE)-score at baseline in predicting survival in adult primary central nervous system lymphoma (PCNSL) patients. Methods: In the HOVON 105/...
15.
van der Meulen M, Dirven L, Habets E, Bakunina K, Smits M, Achterberg H, et al.
Neuro Oncol
. 2021 Feb;
23(8):1315-1326.
PMID: 33560442
Background: To analyze the effect of treatment on neurocognitive functioning and the association of neurocognition with radiological abnormalities in primary central nervous system lymphoma (PCNSL). Methods: One hundred and ninety-nine...
16.
Ferreri A, Doorduijn J, Re A, Cabras M, Smith J, Ilariucci F, et al.
Lancet Haematol
. 2021 Jan;
8(2):e110-e121.
PMID: 33513372
Background: Secondary CNS lymphoma is a rare but potentially lethal event in patients with diffuse large B-cell lymphoma. We aimed to assess the activity and safety of an intensive, CNS-directed...
17.
Dinmohamed A, van der Meulen M, Visser O, Doorduijn J, Bromberg J
Neurooncol Adv
. 2020 Nov;
2(1):vdaa133.
PMID: 33235997
No abstract available.
18.
Donker Kaat L, van der Wielen-Jongen J, Kruit M, Bromberg J, Baas F, Lesnik Oberstein S
Neurol Clin Pract
. 2020 Jul;
10(3):e19-e21.
PMID: 32642329
No abstract available.
19.
Bromberg J, van der Meulen M, Doorduijn J
Curr Oncol Rep
. 2020 Jul;
22(8):78.
PMID: 32602069
Purpose Of Review: The treatment of primary central nervous system lymphoma (PCNSL) is still under debate. One of the issues is the role of rituximab in improving the outcome. Here,...
20.
van der Meulen M, Bromberg J, Nijland M, Visser O, Doorduijn J, Dinmohamed A
Haematologica
. 2020 Apr;
106(2):597-600.
PMID: 32241841
No abstract available.